Burkhard Brandt

Prof. Burkhard Brandt

University Medical Centre Schleswig-Holstein, Institute for Clinical Chemistry, Arnold-Heller-Str.3, 241.05 Kiel, Germany
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2003 in Oncogene
Verified
Journal Article
Closed access
PJPing Ji
Ping Ji
SDSven Diederichs
Sven Diederichs
WWWenbing Wang
Wenbing Wang
SBSebastian Böing
Sebastian Böing
RMRalf Metzger
Ralf Metzger
CMCarsten Müller-Tidow
Carsten Müller-Tidow

1 May 2008 in Nature Reviews Cancer
Verified
Journal Article
Closed access
PDF file
KPKlaus Pantel
Klaus Pantel
RBRuud H. Brakenhoff
Ruud H. Brakenhoff
Burkhard BrandtBurkhard Brandt
Burkhard Brandt

1 May 1999 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
FGFrank Gebhardt
Frank Gebhardt
KZKurt S. Zänker
Kurt S. Zänker
Burkhard BrandtBurkhard Brandt
Burkhard Brandt
The influence of a highly polymorphic CA dinucleotide repeat in the epidermal growth factor receptor (EGFR) gene on transcription was examined with a quantitative nuclear run-off method. We could demonstrate that transcription of the EGFR gene is inhibited by approximately 80% in alleles with 21 CA repeats. In experiments with polymerase chain reaction products that spanned a region of more than 4,000 base pairs and contained the promoter, two enhancers, and the polymorphic region in the first intron of the gene, we found that transcription activity declines with increasing numbers of CA dinucleotides. In vivo pre-mRNA expression data from cultured cell lines support these findings, although other regulation mechanisms can outweigh this effect. In addition, we showed that under our experimental conditions RNA elongation terminates at a site closely downstream of the simple sequence repeat and that there are two separate major transcription start sites. Our results provide new insights in individually different EGFR gene expression and the role of the CA repeat in transcription of this proto-oncogene.

1 June 2002 in Laboratory Investigation
Verified
Journal Article
Open access
PDF file
WBWerner Böcker
Werner Böcker
RMRoland Moll
Roland Moll
CPChristopher Poremba
Christopher Poremba
RHRoland Holland
Roland Holland
PDPaul J van Diest
Paul J van Diest
IBIgor B Buchwallow
Igor B Buchwallow
Breast biology and pathology are currently shaped by the two-cell concept that recognizes only glandular and myoepithelial cells. In the present study, we have visualized a previously unidentified cell population within the epithelial compartment of the breast, which displays the phenotypic characteristics of a committed stem cell. Immunofluorescence double labeling with digital image processing and Western blotting were applied to normal breast tissue as well as to noninvasive and invasive breast cancers using antibodies to basal cytokeratin 5 (Ck5), glandular cytokeratins 8/18 (Ck8/18/19), and smooth muscle α-actin (SMA) as markers for myoepithelial cells (SMA). A distinct population of cells was identified that expressed Ck5 in the absence of Ck8/18/19 or SMA. These cells differentiate toward glandular epithelial or myoepithelial Ck5-negative end cells passing through either Ck5/Ck8/18/19 or Ck5/SMA-positive intermediates. Our experiments clearly demonstrate a precursor or committed stem cell function of the Ck5-positive cell that is responsible for regeneration of the human adult breast epithelium. However, the observation that the vast majority of breast cancers display the glandular epithelial immunophenotype strongly suggests that the neoplastic cells derive from a late stage of the glandular epithelial differentiation pathway. The significance of this new cell biological model is that it might serve as a tool to unravel the regulatory mechanisms that govern regeneration and abnormal proliferation of breast epithelium at the cellular level.

15 March 2006 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
PWPia WülFing
Pia WülFing
JBJulia Borchard
Julia Borchard
HBHorst Buerger
Horst Buerger
SHStefan Heidl
Stefan Heidl
KZKurt S. ZänKer
Kurt S. ZänKer
Burkhard BrandtBurkhard Brandt
Burkhard Brandt
Purpose: Early metastasis in node-negative breast cancer indicates that breast cancer cells obviously can bypass the lymph nodes and disseminate directly hematogenous to distant organs. For this purpose, we evaluated the prognostic value of blood-borne, HER2-positive circulating tumor cells (CTC) in the peripheral blood from 42 breast cancer patients with a median follow-up of 95 months.

19 May 2005 in The Journal of Pathology
Verified
Journal Article
Closed access
PDF file
Eberhard KorschingEberhard Korsching
Eberhard Korsching
JPJens Packeisen
Jens Packeisen
CLCornelia Liedtke
Cornelia Liedtke
DHDaniela Hungermann
Daniela Hungermann
PWPia Wülfing
Pia Wülfing
HBHorst Buerger
Horst Buerger